Alterity Therapeutics Ltd (ATHE) stock
ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF
$1.86−0.09 (-4.85%)
Close on Nov 17, 2026Market cap $33.80MP/E –Yield –
Alterity Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Alterity Therapeutics's price to sales ratio was 73.6× on Aug 30, 2019, against 193.9× a year earlier. Over the last 3 years it ranged from 64.9× to 367.7×, with a median of 183.9×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2019 | Aug 30, 2019 | 73.6× | −6.7 |
| 2018 | Dec 31, 2018 | 80.4× | −188.0 |
| 2017 | Dec 29, 2017 | 268.3× | +127.7 |
| 2016 | Dec 30, 2016 | 140.6× | – |
See a number that looks wrong?